Taken together, our results indicate that memory CD4+ T cells may emerge as a useful predictive marker of distant metastasis of CRC and CRC recurrence, and this subpopulation of lymphocytes may serve as a potential target for the treatment of patients with CRC. The gene discussed is CD4; the disease is colorectal carcinoma.